These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 31719050)
21. The Coexistence of RAS and BRAF Mutations in Metastatic Colorectal Cancer: A Case Report and Systematic Literature Review. Afrăsânie VA; Gafton B; Marinca MV; Alexa-Stratulat T; Miron L; Rusu C; Ivanov AV; Balan GG; Croitoru AE J Gastrointestin Liver Dis; 2020 Jun; 29(2):251-256. PubMed ID: 32530992 [TBL] [Abstract][Full Text] [Related]
22. Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases. Chun YS; Passot G; Yamashita S; Nusrat M; Katsonis P; Loree JM; Conrad C; Tzeng CD; Xiao L; Aloia TA; Eng C; Kopetz SE; Lichtarge O; Vauthey JN Ann Surg; 2019 May; 269(5):917-923. PubMed ID: 28767562 [TBL] [Abstract][Full Text] [Related]
23. RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer. Ta TV; Nguyen QN; Chu HH; Truong VL; Vuong LD Pathol Res Pract; 2020 Apr; 216(4):152898. PubMed ID: 32089414 [TBL] [Abstract][Full Text] [Related]
24. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Vauthey JN; Zimmitti G; Kopetz SE; Shindoh J; Chen SS; Andreou A; Curley SA; Aloia TA; Maru DM Ann Surg; 2013 Oct; 258(4):619-26; discussion 626-7. PubMed ID: 24018645 [TBL] [Abstract][Full Text] [Related]
25. Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group. Modest DP; Ricard I; Heinemann V; Hegewisch-Becker S; Schmiegel W; Porschen R; Stintzing S; Graeven U; Arnold D; von Weikersthal LF; Giessen-Jung C; Stahler A; Schmoll HJ; Jung A; Kirchner T; Tannapfel A; Reinacher-Schick A Ann Oncol; 2016 Sep; 27(9):1746-53. PubMed ID: 27358379 [TBL] [Abstract][Full Text] [Related]
26. Overall Survival, BRAF, RAS, and MSI Status in Patients Who Underwent Cetuximab After Refractory Chemotherapy for Metastatic Colorectal Cancer. Santos FA; Reis RM; Barroti LC; Pereira AAL; Matsushita MM; de Carvalho AC; Datorre JG; Berardinelli GN; Araujo RLC J Gastrointest Cancer; 2024 Mar; 55(1):344-354. PubMed ID: 37608030 [TBL] [Abstract][Full Text] [Related]
27. Association between clinicopathological characteristics and RAS mutation in colorectal cancer. Rimbert J; Tachon G; Junca A; Villalva C; Karayan-Tapon L; Tougeron D Mod Pathol; 2018 Mar; 31(3):517-526. PubMed ID: 29052598 [TBL] [Abstract][Full Text] [Related]
28. Distinct Genomic Profiles are Associated With Conversion to Resection and Survival in Patients With Initially Unresectable Colorectal Liver Metastases Treated With Systemic and Hepatic Artery Chemotherapy. Datta J; Narayan RR; Goldman DA; Chatila WK; Gonen M; Strong J; Balachandran VP; Drebin JA; Kingham TP; Jarnagin WR; Schultz N; Kemeny NE; D'Angelica MI Ann Surg; 2022 Nov; 276(5):e474-e482. PubMed ID: 33214457 [TBL] [Abstract][Full Text] [Related]
29. Clinical relevance of alterations in quantity and quality of plasma DNA in colorectal cancer patients: based on the mutation spectra detected in primary tumors. Lin JK; Lin PC; Lin CH; Jiang JK; Yang SH; Liang WY; Chen WS; Chang SC Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S680-6. PubMed ID: 24841357 [TBL] [Abstract][Full Text] [Related]
30. BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy. Teng HW; Huang YC; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Wang HW; Chang SC; Lan YT; Lin CC; Wang HS; Yang SH J Surg Oncol; 2012 Aug; 106(2):123-9. PubMed ID: 22331825 [TBL] [Abstract][Full Text] [Related]
31. Mitochondrial DNA alteration in primary and metastatic colorectal cancer: Different frequency and association with selected clinicopathological and molecular markers. Kleist B; Meurer T; Poetsch M Tumour Biol; 2017 Mar; 39(3):1010428317692246. PubMed ID: 28345467 [TBL] [Abstract][Full Text] [Related]
36. Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR. Nagakubo Y; Hirotsu Y; Amemiya K; Oyama T; Mochizuki H; Omata M BMC Med Genomics; 2019 Nov; 12(1):162. PubMed ID: 31711486 [TBL] [Abstract][Full Text] [Related]
37. Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients. Xu X; Huang F; Cao M; Chen X; Wang H; Jiang H; Yu Y; Shen M; Yang Y; Wang B; Liu T; Guo W J Clin Lab Anal; 2021 Sep; 35(9):e23818. PubMed ID: 34403504 [TBL] [Abstract][Full Text] [Related]
38. Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer. Hamfjord J; Guren TK; Glimelius B; Sorbye H; Pfeiffer P; Dajani O; Lingjaerde OC; Tveit KM; Pallisgaard N; Spindler KG; Kure EH Int J Cancer; 2021 Sep; 149(6):1385-1397. PubMed ID: 33961700 [TBL] [Abstract][Full Text] [Related]
39. Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy. Vidal J; Bellosillo B; Santos Vivas C; García-Alfonso P; Carrato A; Cano MT; García-Carbonero R; Élez E; Losa F; Massutí B; Valladares-Ayerbes M; Viéitez JM; Manzano JL; Azuara D; Gallego J; Pairet S; Capellá G; Salazar R; Tabernero J; Aranda E; Montagut C Ann Oncol; 2019 Mar; 30(3):439-446. PubMed ID: 30689692 [TBL] [Abstract][Full Text] [Related]
40. The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern. Prasanna T; Karapetis CS; Roder D; Tie J; Padbury R; Price T; Wong R; Shapiro J; Nott L; Lee M; Chua YJ; Craft P; Piantadosi C; Sorich M; Gibbs P; Yip D Acta Oncol; 2018 Nov; 57(11):1438-1444. PubMed ID: 30035653 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]